Antares Pharma Inc. (AMEX:AIS) a leader in self-injection drug delivery technology, announced the latest advancement in its proprietary line of VIBEX auto-injectors. Antares’ new VIBEX QS auto-injector platform offers a dose capacity of 1 mL and greater in a compact design.
Antares Pharma focuses on self-injection pharmaceutical products and topical gel-based medicines. The Company's subcutaneous and intramuscular injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Valeo/Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, Antares Pharma has a multi-product deal with Teva Pharmaceutical Industries, Ltd that includes Tev-Tropin human growth hormone and a partnership with Ferring Pharmaceuticals.
Alpha Pro Tech Ltd. (AMEX:APT) announced financial results for the three and nine months ended September 30, 2010.
Alpha Pro Tech, Ltd. is the parent company of Alpha Pro Tech, Inc. and Alpha ProTech Engineered Products, Inc. Alpha Pro Tech, Inc. develops, manufactures and markets innovative disposable and limited-use protective apparel products for the industrial, clean room, medical and dental markets. Alpha ProTech Engineered Products, Inc. manufactures and markets a line of construction weatherization products, including building wrap and roof underlayment.
Global Hunter Corp.'s focus is on strategic and base metals, particularly copper and molybdenum. Global Hunter has built an outstanding portfolio of projects in the stable geopolitical geographies of Canada and Chile. Global Hunter's exploration and development teams are on the ground rapidly advancing the La Corona de Cobre property near La Serena, Chile and the Rabbit South property in British Columbia, Canada. Either one of these projects could carry Global Hunter forward on a stand-alone basis, but together they bring Global Hunter additional stability, strength and value.
Molybdenum is a metallic, silvery-white element which is very stable chemically but it will react with acids. The physical characteristic that makes molybdenum unique is that it has a very high melting point, 4,730 degrees Fahrenheit. This is 2,000 degrees higher than the melting point of steel. It is 1,000 degrees higher than the melting temperature of most rocks. Molybdenum is the 54th most abundant element in the Earth's crust and the 25th most abundant element in the oceans, with an average of 10 parts per billion; it is the 42nd most abundant element in the Universe.
Rabbit South, BC Project
Global Hunter's Rabbit South molybdenum project is located within a prolific mining region in the Dominic and Roper Lake area, 27 kilometres west-southwest of the city of Kamloops British Columbia. The property is accessible year round by a combination of highway and logging roads. Rabbit South is situated 25 kilometres northeast of Highland Valley, BC's largest porphyry copper mine (1.4 billion tonnes @ 0.40% Cu) and 12 kilometres southwest of Afton, BC's richest porphyry copper mine (107Mi tonnes @ 1.05% Cu, 0.70g/t Au).
The area has been the subject of molybdenum exploration dating back to 1960. Between 1979 and 1981 an extensive exploration program including 69 percussion drill holes and 10 diamond drill holes identified the Roper Lake Molybdenum Target. A non-code-complaint resource of 65 million tonnes at 0.065% of Molybdenum was identified in two zones. Zone A measures 600 metres in length and is 300 meters wide by 60 metres deep, while Zone B has been outlined for 500 metres in length, 400 metres in width and 70 metres in depth.
Additional drilling by Global Hunter has confirmed the existence of extensive near-surface molybdenum mineralization and efforts to correlate previous drill results and to complete an updated resource estimate are underway. Initial results indicate the system is capable of producing much higher grade Mo mineralization on a small scale. It remains to be determined if the system can do that on a deposits-scale.
To learn more about Global Hunter visit: http://www.globalhunter.ca
MusclePharm Corporation (OTCQB:MSLP)
MusclePharm Corporation is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.
The partnership begins in 2011 and MSLP will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.
In four short years, the WBFF has grown to become a popular destination for aspiring professional bodybuilders and fitness competitors. In 2010 alone, participants from more than 25 different countries competed in the WBFF World Championships, which featured many of the world’s top fitness athletes.
MSLP ’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. MSLP is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance.
To learn more about MSLP visit: http://www.musclepharm.com
Neostem, Inc. (AMEX:NBS) an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals, announced the closing of concurrent offerings.
NeoStem, Inc. is engaged in the development of stem cell-based therapies, pursuit of anti-aging initiatives and building of a network of adult stem cell collection centers in the U.S. and China that are focused on enabling people to donate and store their own (autologous) stem cells for their personal use in times of future medical need. The Company also has licensed various stem cell technologies, including a worldwide exclusive license to VSEL™ Technology which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye, manufactures and distributes generic antibiotics in China.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from a third party for (thirty) days of advertising for Global Hunter Corp. (TSX Venture Exchange (TSX.VOB) and the Frankfurt Stock Exchange (FSE:G5D). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP).